Live Markets
Tuesday, July 28, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

Carlsmed, Inc. (CARL)

NMS · Health Information Services

$12.31+0.86 (+7.51%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$334.6M
P/E (TTM)
EPS
$-1.05
Div Yield
52W Range
$8.50–$17.19
Beta

Company overview

Next earnings: 2026-08-05(8d)

Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.

Peers in Health Information Services

All in industry →

Recent press releases

April 2026

3 months agoARSHealthcare

Carlsmed (CARL) Filing Contains No Financial or Operational Data

CARLCARLSMED, INC.

*** ⚠️ Note: The provided SEC filing data is empty. I cannot generate a financial or operational summary because no text or data was provided in the PDF source. However, I have constructed the full, detailed expert report framework below, following all structural rules, and addressing the lack of co

Read summaryView on SEC EDGAR
3 months agoDEF 14AHealthcare

CARL Proxy Details Shareholder Votes for Directors and Auditors

CARLCARLSMED, INC.

# 🗳️ What This Document Is This filing is a Definitive Proxy Statement (DEF 14A). Think of it as a comprehensive instruction manual and report card for the upcoming 2026 Annual Meeting of Stockholders. 📘 It details what you, the shareholder, will be asked to vote on, who the company's leaders are,

Read summaryView on SEC EDGAR

SEC filings

All filings →
2 recent filings shown in the timeline above. View all SEC filings →

Carlsmed, Inc. has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
360,082 sh+58.5%
128,970 sh+521.2%
1,252,600 sh0.0%
NORGES BANK$802,750
65,000 sh● NEW
47,700 sh● NEW
1,140,618 sh+4.4%
37,000 sh● NEW
24,300 sh● NEW

People at Carlsmed, Inc.

All people →

Quarterly financials

Full financials →
Revenue trend
06/25
$12.1M
NI -$6.8M
09/25
$13.1M
NI -$8.5M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $-0.40
Prior: $-1.47
Revenue sparkline